Annual CAPEX:
$3.99M-$15.05M(-79.06%)Summary
- As of today, GLUE annual capital expenditures is $3.99 million, with the most recent change of -$15.05 million (-79.06%) on December 31, 2024.
- During the last 3 years, GLUE annual CAPEX has fallen by -$5.74 million (-59.02%).
- GLUE annual CAPEX is now -79.06% below its all-time high of $19.04 million, reached on December 31, 2023.
Performance
GLUE CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CAPEX:
$651.00K-$1.04M(-61.59%)Summary
- As of today, GLUE quarterly capital expenditures is $651.00 thousand, with the most recent change of -$1.04 million (-61.59%) on September 30, 2025.
- Over the past year, GLUE quarterly CAPEX has increased by +$252.00 thousand (+63.16%).
- GLUE quarterly CAPEX is now -92.91% below its all-time high of $9.18 million, reached on March 31, 2023.
Performance
GLUE Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$4.12M+$252.00K(+6.52%)Summary
- As of today, GLUE TTM capital expenditures is $4.12 million, with the most recent change of +$252.00 thousand (+6.52%) on September 30, 2025.
- Over the past year, GLUE TTM CAPEX has dropped by -$1.38 million (-25.08%).
- GLUE TTM CAPEX is now -83.28% below its all-time high of $24.62 million, reached on September 30, 2023.
Performance
GLUE TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
GLUE CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -79.1% | +63.2% | -25.1% |
| 3Y3 Years | -59.0% | -53.5% | -52.7% |
| 5Y5 Years | +187.9% | -30.0% | +342.6% |
GLUE CAPEX Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -79.1% | at low | -92.9% | +255.7% | -83.3% | +6.5% |
| 5Y | 5-Year | -79.1% | +187.9% | -92.9% | +255.7% | -83.3% | +342.6% |
| All-Time | All-Time | -79.1% | +187.9% | -92.9% | +255.7% | -83.3% | +342.6% |
GLUE CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $651.00K(-61.6%) | $4.12M(+6.5%) |
| Jun 2025 | - | $1.70M(+6.8%) | $3.86M(-7.8%) |
| Mar 2025 | - | $1.59M(+767.2%) | $4.19M(+5.1%) |
| Dec 2024 | $3.99M(-79.1%) | $183.00K(-54.1%) | $3.99M(-27.4%) |
| Sep 2024 | - | $399.00K(-80.3%) | $5.49M(-18.7%) |
| Jun 2024 | - | $2.02M(+46.1%) | $6.75M(-39.9%) |
| Mar 2024 | - | $1.38M(-18.1%) | $11.24M(-40.9%) |
| Dec 2023 | $19.04M(+47.5%) | $1.69M(+1.8%) | $19.04M(-22.7%) |
| Sep 2023 | - | $1.66M(-74.5%) | $24.62M(+1.1%) |
| Jun 2023 | - | $6.51M(-29.1%) | $24.36M(+19.4%) |
| Mar 2023 | - | $9.18M(+26.3%) | $20.41M(+58.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $12.91M(+32.7%) | $7.27M(+419.4%) | $12.91M(+48.4%) |
| Sep 2022 | - | $1.40M(-45.2%) | $8.70M(-3.9%) |
| Jun 2022 | - | $2.55M(+51.3%) | $9.05M(-1.6%) |
| Mar 2022 | - | $1.69M(-44.9%) | $9.20M(-5.4%) |
| Dec 2021 | $9.73M(+187.2%) | $3.06M(+74.3%) | $9.73M(+45.8%) |
| Sep 2021 | - | $1.75M(-35.0%) | $6.67M(+14.1%) |
| Jun 2021 | - | $2.70M(+21.8%) | $5.85M(+85.8%) |
| Mar 2021 | - | $2.22M(+138.4%) | $3.15M(+238.4%) |
| Dec 2020 | $3.39M(+144.7%) | - | - |
| Sep 2020 | - | $930.00K | $930.00K |
| Dec 2019 | $1.39M | - | - |
FAQ
- What is Monte Rosa Therapeutics, Inc. annual capital expenditures?
- What is the all-time high annual CAPEX for Monte Rosa Therapeutics, Inc.?
- What is Monte Rosa Therapeutics, Inc. annual CAPEX year-on-year change?
- What is Monte Rosa Therapeutics, Inc. quarterly capital expenditures?
- What is the all-time high quarterly CAPEX for Monte Rosa Therapeutics, Inc.?
- What is Monte Rosa Therapeutics, Inc. quarterly CAPEX year-on-year change?
- What is Monte Rosa Therapeutics, Inc. TTM capital expenditures?
- What is the all-time high TTM CAPEX for Monte Rosa Therapeutics, Inc.?
- What is Monte Rosa Therapeutics, Inc. TTM CAPEX year-on-year change?
What is Monte Rosa Therapeutics, Inc. annual capital expenditures?
The current annual CAPEX of GLUE is $3.99M
What is the all-time high annual CAPEX for Monte Rosa Therapeutics, Inc.?
Monte Rosa Therapeutics, Inc. all-time high annual capital expenditures is $19.04M
What is Monte Rosa Therapeutics, Inc. annual CAPEX year-on-year change?
Over the past year, GLUE annual capital expenditures has changed by -$15.05M (-79.06%)
What is Monte Rosa Therapeutics, Inc. quarterly capital expenditures?
The current quarterly CAPEX of GLUE is $651.00K
What is the all-time high quarterly CAPEX for Monte Rosa Therapeutics, Inc.?
Monte Rosa Therapeutics, Inc. all-time high quarterly capital expenditures is $9.18M
What is Monte Rosa Therapeutics, Inc. quarterly CAPEX year-on-year change?
Over the past year, GLUE quarterly capital expenditures has changed by +$252.00K (+63.16%)
What is Monte Rosa Therapeutics, Inc. TTM capital expenditures?
The current TTM CAPEX of GLUE is $4.12M
What is the all-time high TTM CAPEX for Monte Rosa Therapeutics, Inc.?
Monte Rosa Therapeutics, Inc. all-time high TTM capital expenditures is $24.62M
What is Monte Rosa Therapeutics, Inc. TTM CAPEX year-on-year change?
Over the past year, GLUE TTM capital expenditures has changed by -$1.38M (-25.08%)